UR Medicine’s Wilmot Cancer Institute is set to open its 14th cancer care centre at 875 Hard Rd. in Webster, New York, on 11 July.
The new Wilmot Cancer Institute will offer multidisciplinary services to patients that include medical oncology, radiation oncology, surgical oncology, clinical trials, among others.
The 21,000sq ft facility was designed by Rozzi Architects and built by Russell P LeFrois Builders & Developers. The Cabot Group managed the $6.7m project, which also includes a $3.7m linear accelerator for radiation treatment.
The building features 18 exam rooms, 11 infusion chairs, a conference room with videoconferencing capabilities and on-site parking.
It also has a Varian TrueBeam system with latest imaging and respiratory gating.
Once it opens, the cancer care centre will particularly benefit patients coming to Wilmot from the greater Webster area.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Wilmot Cancer Institute Regional Operations associate director Daniel Mulkerin said, “Wilmot continues to extend the benefits of a university cancer centre and programme into communities where patients live.
“More than half of Wilmot’s patients receive their care at regional locations, and we are thrilled to be able to open the doors to the Wilmot Cancer Institute Webster to serve that need in the greater Webster area.”
Patients at the new centre will also have access to clinical trials later this year. The trials will be available for various types of cancers.
“We aren’t just offering exceptional clinical care in Webster, but offering access to innovative care in the forms of research through clinical trial accessibility to patients throughout the 27-county region we serve,” added Mulkerin.